TCGA study of liver cancer reveals potential targets for therapy

http://huntersneeds.net/rigaro/1652 Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumorsa��including mutations in tumor-suppressing genes and high expression of immune checkpoint genesa��that could be targets for drugs that already exist.

broker option navigator …read more

http://hickscountry.com/2015/08/28/44-pa-cmt-most-popular-country-artist-chart/ Source:: Cancer